Keybank National Association OH Sells 7,508 Shares of CME Group Inc. $CME

Keybank National Association OH lowered its holdings in shares of CME Group Inc. (NASDAQ:CME) by 5.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 133,820 shares of the financial services provider’s stock after selling 7,508 shares during the quarter. Keybank National Association OH’s holdings in CME Group were worth $35,058,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. 71 West Capital Partners increased its position in CME Group by 5.5% during the third quarter. 71 West Capital Partners now owns 1,108 shares of the financial services provider’s stock worth $290,000 after buying an additional 58 shares during the last quarter. Nemes Rush Group LLC raised its holdings in CME Group by 0.6% during the third quarter. Nemes Rush Group LLC now owns 73,396 shares of the financial services provider’s stock valued at $19,228,000 after buying an additional 456 shares in the last quarter. M&G PLC raised its holdings in CME Group by 20.0% during the third quarter. M&G PLC now owns 1,329,259 shares of the financial services provider’s stock valued at $348,266,000 after buying an additional 221,469 shares in the last quarter. Vestor Capital LLC lifted its position in shares of CME Group by 19.0% in the third quarter. Vestor Capital LLC now owns 10,250 shares of the financial services provider’s stock worth $2,685,000 after buying an additional 1,636 shares during the last quarter. Finally, AlphaCore Capital LLC lifted its position in shares of CME Group by 7.0% in the third quarter. AlphaCore Capital LLC now owns 3,720 shares of the financial services provider’s stock worth $975,000 after buying an additional 242 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Performance

NASDAQ:CME opened at $315.86 on Thursday. CME Group Inc. has a 1 year low of $218.31 and a 1 year high of $329.16. The firm’s fifty day simple moving average is $284.54 and its 200 day simple moving average is $281.22. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a market capitalization of $113.06 billion, a PE ratio of 25.46, a PEG ratio of 3.77 and a beta of 0.15.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share for the quarter, topping analysts’ consensus estimates of $2.99 by $0.03. The firm had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.71 billion. CME Group had a net margin of 63.33% and a return on equity of 16.23%. The business’s revenue was up 10.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.68 EPS. On average, sell-side analysts anticipate that CME Group Inc. will post 12.35 EPS for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 30th. Stockholders of record on Friday, December 11th will be given a $1.30 dividend. This represents a $5.20 annualized dividend and a dividend yield of 1.6%. The ex-dividend date of this dividend is Friday, December 11th. CME Group’s dividend payout ratio (DPR) is currently 42.66%.

Analysts Set New Price Targets

Several analysts have recently issued reports on the company. Barclays upped their price target on CME Group from $281.00 to $321.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 22nd. Piper Sandler reissued an “overweight” rating and issued a $330.00 price objective (up from $295.00) on shares of CME Group in a research note on Thursday, October 22nd. Wall Street Zen upgraded CME Group from a “sell” rating to a “hold” rating in a report on Saturday, October 31st. UBS Group boosted their target price on CME Group from $270.00 to $310.00 and gave the stock a “neutral” rating in a report on Thursday, October 22nd. Finally, Weiss Ratings raised CME Group from a “buy (b-)” rating to a “buy (b)” rating in a research report on Friday, October 23rd. Ten equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $314.44.

Insider Buying and Selling

In other news, insider Sunil Cutinho sold 5,000 shares of CME Group stock in a transaction dated Tuesday, October 27th. The stock was sold at an average price of $298.70, for a total value of $1,493,500.00. Following the transaction, the insider directly owned 20,037 shares in the company, valued at approximately $5,985,051.90. The trade was a 19.97% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Julie Winkler sold 10,079 shares of the business’s stock in a transaction dated Monday, November 2nd. The stock was sold at an average price of $305.15, for a total value of $3,075,606.85. Following the transaction, the insider directly owned 21,482 shares of the company’s stock, valued at $6,555,232.30. This represents a 31.93% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 33,511 shares of company stock valued at $9,714,580 in the last quarter. Insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.